Analysts Viewpoint
SILO Pharma Inc’s latest rating changes from various analysts
SILO Pharma Inc’s recently made public that its CEO and President Weisblum Eric acquired Company’s shares for reported $812.0 on
Menu
SILO Pharma Inc’s recently made public that its CEO and President Weisblum Eric acquired Company’s shares for reported $812.0 on
In a filing, SILO Pharma Inc revealed its CEO and President Weisblum Eric acquired Company’s shares for reported $812.0 on